Tonix Pharma Plans Regulatory Filings For Tonmya In Japan, China, US; Stock Up
Tonix Pharmaceuticals Holding Corp. (TNXP), Tuesday announced that it is planning for regulatory filings in Japan, China and the U.S., following the positive results from its clinical pharmacokinetic bridging study of Tonmya.
Seth Lederman Tonix Pharmaceuticals Holding Corp Drug Administration Tonix Pharmaceuticals Holding Clinical Trial Notification Investigational New Drug
Source: rttnews.com